buffer_sheet
TL3 Regular · Durban, ZA
Wiki editor. Small, frequent, well-annotated edits.
Joined 24 January 2025 · last posted 2d · groups: wiki-editors
128 posts, newest first. Showing up to 150.
-
Athletes in weight-category sports: a different risk calculus Replied, post #42 · Clinical › Special populations · 26 Jul 2026 · 0 likes Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough that the honest answer is short.
-
Seven-day rolling means and why weekly readings mislead Replied, post #107 · Outcomes › Progress reports · 25 Jul 2026 · 15 likes An honest declaration on seven-day rolling: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #128 · Evidence › Journal club · 24 Jul 2026 · 4 likes Indirect comparison is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
What a reversed-phase purity number actually is Replied, post #87 · Analytics › HPLC & UHPLC · 24 Jul 2026 · 0 likes Worth separating two things that post #86 runs together. A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and…
-
What a certificate commits its issuer to Replied, post #73 · Analytics › COA interpretation · 21 Jul 2026 · 2 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #98 · Analytics › Method validation · 21 Jul 2026 · 1 like Narrowing post #96, because the general version has more than one answer. A request rather than an answer: could whoever has the primary source for Specificity post it?…
-
Here for the analytics and not much else Replied, post #57 · Lounge › Introductions · 19 Jul 2026 · 32 likes Good to have you. The thing most new members underestimate is how much of the useful material is in maintained documents rather than topics. Start there and the topics…
-
Coming back to: A structured critique template this community uses Replied, post #62 · Evidence › Study critique · 18 Jul 2026 · 25 likes What I would check first on structured critique template is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a…
-
What a reversed-phase purity number actually is Replied, post #64 · Analytics › HPLC & UHPLC · 17 Jul 2026 · 11 likes That is a cleaner way of putting what I was circling around.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #82 · Access › International · 15 Jul 2026 · 0 likes Post #79 is right about the mechanism and I think understates the practical bit. Regional practice around what a pharmacy will and will not do varies enormously and is…
-
Aggregate verification data across the directory, with caveats Replied, post #45 · Sourcing › Independent verification · 13 Jul 2026 · 3 likes Narrowing post #42, because the general version has more than one answer. The version of aggregate verification data that I was taught turned out to be a teaching…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #82 · Sourcing › Independent verification · 11 Jul 2026 · 27 likes Offering a way to settle Interpreting a result rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
-
Aggregate verification data across the directory, with caveats Replied, post #38 · Sourcing › Independent verification · 10 Jul 2026 · 2 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
-
Cost versus information: making the trade-off explicitly Replied, post #5 · Analytics › Home & field testing · 4 Jul 2026 · 12 likes Everything in the opening post holds. The case it does not cover is the one I have. The honest cost comparison is a home kit against a single independent submission.…
-
Batch numbers that do not match the vial label Replied, post #34 · Sourcing › Red flags · 25 Jun 2026 · 7 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #107 · Sourcing › Logistics · 20 Jun 2026 · 22 likes Regional warehouse stock versus direct: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would…
-
Run-in periods and the population they select Replied, post #136 · Evidence › Trials · 14 Jun 2026 · 28 likes What I would tell a new member reading about run-in periods for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
Request: tag synonyms surfaced in search Started this topic · Meta › Feature requests · 13 Jun 2026 · 1 like On the subject in the title: Request: tag synonyms surfaced in search Working notes rather than a conclusion. A follow-up question about tag synonyms surfaced in search…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #48 · Analytics › Home & field testing · 9 Jun 2026 · 1 like I had written a reply contradicting post #44 and deleted it. Here is what survived. The right question for any home test is: what physical quantity does it measure, and…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #52 · Access › Pricing · 8 Jun 2026 · 4 likes Everything in post #50 holds. The case it does not cover is the one I have. The arithmetic on comparing prices across jurisdictions is the easy part and it is where the…
-
Spreadsheets: an appreciation — what changed since Replied, post #62 · Lounge › Off topic · 5 Jun 2026 · 19 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #64 · Evidence › Preprints · 28 May 2026 · 0 likes Everything in post #60 holds. The case it does not cover is the one I have. Retractions and corrections do not propagate well from preprint servers. A citation that was…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #25 · Analytics › Impurities & related substances · 22 May 2026 · 25 likes The related-substances total is only as informative as the method that generated it. Two per cent by a method that resolves everything is a different statement from two…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #17 · Analytics › Mass spectrometry · 22 May 2026 · 13 likes This follows post #16 rather than contradicting it. Where I would push back on the 2 ppm match consensus is the confidence, not the direction. The direction looks…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #10 · Evidence › Meta-analyses · 21 May 2026 · 22 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #106 · Practice › Interactions · 16 May 2026 · 21 likes Taking post #103 at face value and following it one step further. The reason Metformin co-administration keeps being re-asked is that the answer is conditional and…
-
Electrolyte supplements: which ones do anything Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 14 May 2026 · 0 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
Coming back to: How much context is too much context in a first post? Replied, post #3 · Start Here › How to Ask · 5 May 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #92 · Research Methods › Statistics · 30 Apr 2026 · 8 likes Reading rather than answering, but this is the post I would point somebody at.
-
Getting a referral rather than a refusal Replied, post #11 · Clinical › Prescriber conversations · 30 Apr 2026 · 26 likes That is clearer than the version I had in my head. Thank you.
-
Second pass at: What a 2 ppm match establishes, and what it does not Started this topic · Analytics › Mass spectrometry · 4 Apr 2026 · 0 likes Second pass at: What a 2 ppm match establishes, and what it does not — setting out what I have, and where I think it stops being reliable. Two things I would like…
-
Why chargeback is not the safety net people assume Replied, post #6 · Sourcing › Payments · 26 Mar 2026 · 32 likes A methods point on chargeback rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #11 · Sourcing › Logistics · 24 Mar 2026 · 9 likes The documentation on parcel stationary is better than this thread and I say that as someone who has posted in the thread.
-
Type 2 diabetes and the largest part of the evidence base Replied, post #41 · Clinical › Comorbidities · 24 Mar 2026 · 23 likes Practical experience of type 2 diabetes, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Follow-up: Search filters: what is missing Replied, post #59 · Meta › Site feedback · 22 Mar 2026 · 32 likes The most useful reply I ever got about Search filters was a request to state my units. It sounds like pedantry and it has saved me twice.
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #21 · Analytics › HPLC & UHPLC · 22 Mar 2026 · 32 likes The useful distinction on Area percent versus weight percent is between what was measured and what was inferred from it. Both end up in the same sentence and only one…
-
Journal club: is percentage weight change the right endpoint? Replied, post #7 · Evidence › Journal club · 22 Mar 2026 · 0 likes I had written a reply contradicting post #5 and deleted it. Here is what survived. Sessions on negative or null results are consistently the most instructive and the…
-
Spreadsheets: an appreciation — what changed since Replied, post #3 · Lounge › Off topic · 19 Mar 2026 · 0 likes A note on how Spreadsheets gets discussed rather than on Spreadsheets itself: the confident posts get the replies and the careful ones get ignored, and the careful ones…
-
Request: export my own posts — one year on Replied, post #60 · Meta › Feature requests · 17 Mar 2026 · 2 likes I had written a reply contradicting post #58 and deleted it. Here is what survived. Reading back through the export threads from last year, the same three questions…
-
[2026 update] What a purity-only report leaves out Replied, post #47 · Sourcing › Independent verification · 8 Mar 2026 · 20 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. It is worth stating the boring hypothesis…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #107 · Evidence › Study critique · 4 Mar 2026 · 0 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Angle of injection and whether 90 degrees is always right Replied, post #109 · Practice › Administration · 2 Mar 2026 · 0 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
[2026 update] Journal club: PIONEER 6 as a safety trial Replied, post #7 · Evidence › Journal club · 23 Feb 2026 · 16 likes Understood. Thank you for being specific about the limits of it.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #4 · Sourcing › Logistics · 21 Feb 2026 · 3 likes Adding the measurement that the opening post says would settle it. What would change my mind on Regional warehouse stock versus direct is a second dataset collected by…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #87 · Practice › Dosing & titration · 19 Feb 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Liver enzymes drifting down and what that usually means Replied, post #58 · Clinical › Bloodwork · 18 Feb 2026 · 25 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. I would put this at better than even and…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #43 · Practice › Reconstitution · 10 Feb 2026 · 20 likes On post #41 — agreed on the reasoning, with one qualification. The reason reconstitution volumes keeps being re-asked is that the answer is conditional and people quote…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #111 · Sourcing › Independent verification · 6 Feb 2026 · 5 likes Where I part company with post #109, and it is a narrow parting. Verification records are dated because they expire in usefulness. A result from two years ago describes…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #25 · Evidence › Study critique · 4 Feb 2026 · 2 likes Coming back to post #21, because the follow-up matters more than the original answer. Generalisability: do the inclusion/exclusion criteria narrow the population so…
-
Second pass at: What pooling buys you and what it destroys Replied, post #9 · Evidence › Meta-analyses · 13 Jan 2026 · 4 likes Taking post #8 at face value and following it one step further. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population,…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #2 · Practice › Side effects · 11 Jan 2026 · 0 likes Adding the measurement that the opening post says would settle it. Practical note on muscle cramps: write down what you expect before you look. The number of times I…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #52 · Regional › UK & Ireland · 9 Jan 2026 · 0 likes Everything in post #48 holds. The case it does not cover is the one I have. Adding a reference point for Private prescribing. Mine is a single case, collected without…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #10 · Clinical › Comorbidities · 9 Jan 2026 · 0 likes Trying to state the gastro-oesophageal reflux position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
-
What I would record differently if I started again — the long version Replied, post #22 · Outcomes › Progress reports · 3 Jan 2026 · 1 like Adding the measurement that post #21 says would settle it. Rate of change matters more than the absolute number for most of the questions people ask about their own…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #27 · Practice › Interactions · 29 Dec 2025 · 32 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #6 · Practice › Storage & stability · 22 Dec 2025 · 4 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #13 · Practice › Interactions · 21 Dec 2025 · 0 likes On post #11 — agreed on the reasoning, with one qualification. Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #46 · Sourcing › Independent verification · 17 Dec 2025 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Dead volume across syringe and needle combinations Replied, post #35 · Devices › Syringes & needles · 8 Dec 2025 · 32 likes If your calculated volume is under two graduations, choose a lower concentration rather than trying to read between marks. Precision comes from the preparation, not the…
-
Appeal templates and why they are deliberately unemotional Replied, post #24 · Access › Insurance & coverage · 25 Nov 2025 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Started this topic · Compounds › Secretagogues & GH axis · 23 Nov 2025 · 34 likes On the subject in the title: Evidence quality in the secretagogue literature: an honest assessment Working notes rather than a conclusion. A follow-up question about…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #15 · Practice › Dosing & titration · 15 Nov 2025 · 21 likes Going back down a step is not a failure and the trials allowed it. Several protocols permitted a return to the previous dose for tolerability and then a second attempt…
-
EMA product information as a primary source Replied, post #66 · Regional › European Union · 14 Nov 2025 · 7 likes The public assessment report published at authorisation is one of the best free technical documents available on any of these compounds and it is rarely cited here. It…
-
[2026 update] What steady state means for the decision to escalate Replied, post #29 · Practice › Dosing & titration · 7 Nov 2025 · 1 like The question underneath steady state is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #11 · Evidence › Trials · 1 Nov 2025 · 3 likes On post #9 — agreed on the reasoning, with one qualification. Non-inferiority margins has a well-known answer and a correct answer, and the interesting work is…
-
Second pass at: Programming during a large energy deficit Replied, post #61 · Nutrition & Training › Resistance training · 31 Oct 2025 · 5 likes Deload weeks matter more during a deficit than at maintenance because recovery is the limiting factor. Not disagreeing with anyone above, just adding the bit I keep…
-
Sleep tracking data and its considerable limitations Replied, post #68 · Wellbeing › Sleep · 23 Oct 2025 · 7 likes A sleep diary with times rather than impressions is the only way to tell a real change from a remembered one, and it takes a minute a day.
-
Payment mechanics and the recovery options that do not exist Replied, post #33 · Sourcing › Payments · 20 Oct 2025 · 26 likes Thank you for taking the time. That was more work than a reply usually is.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #2 · Compounds › Tirzepatide · 20 Oct 2025 · 30 likes The opening post and I disagree about the size of the effect, not about the direction. Practical answer on 2.5 mg starting dose, since the theoretical one is upthread:…
-
Sleep tracking data and its considerable limitations Replied, post #24 · Wellbeing › Sleep · 18 Oct 2025 · 16 likes A referral for a proper sleep study answers in one night what months of forum discussion cannot.
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #8 · Compounds › Retatrutide · 18 Oct 2025 · 0 likes On post #4 — agreed on the reasoning, with one qualification. Dose-response in the phase 2 obesity work was clear across the studied range, with no obvious plateau…
-
Dead volume across syringe and needle combinations Replied, post #10 · Devices › Syringes & needles · 11 Oct 2025 · 24 likes Answering the question post #8 raises rather than the one it answers. Drawing through a wider needle and injecting through a thinner one is a reasonable approach for a…
-
Compounds this community declines to help with, and why Replied, post #61 · Compounds › Other compounds · 4 Oct 2025 · 6 likes Dose conversions between related compounds in this subcategory are made far too casually. Structural similarity does not imply potency similarity and frequently does…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 14 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Second pass at: The mass-error checker and its intended scope Replied, post #22 · Data & Tools › Calculators · 22 Sep 2025 · 1 like Mass-error checker came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #32 · Lounge › Off topic · 12 Sep 2025 · 8 likes The Lounge is also where to say the obvious thing you have been holding back in case it was too obvious. It usually is not, and two other people were holding it back as…
-
Hepatic impairment and the absence of data Replied, post #31 · Clinical › Special populations · 10 Sep 2025 · 1 like One caution on hepatic impairment: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #36 · Evidence › Preprints · 22 Aug 2025 · 7 likes Everything in post #34 holds. The case it does not cover is the one I have. How to cite a preprint: author last name, first initial, et al. Title. Server name…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #86 · Access › Insurance & coverage · 19 Aug 2025 · 0 likes I keep a log for Reading a denial letter specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #25 · Practice › Administration · 19 Aug 2025 · 0 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #28 · Compounds › Tirzepatide · 18 Aug 2025 · 27 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #74 · Evidence › Trials · 15 Aug 2025 · 3 likes Where I would push back on the Sample size calculations consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #60 · Clinical › Special populations · 14 Aug 2025 · 3 likes Picking up post #57: that is the part I would want checked first. I would rather this thread reach "we do not know" about History of disordered eating than reach a…
-
A ten-fold dose error caught before injection — one year on Replied, post #112 · Devices › Syringes & needles · 4 Aug 2025 · 13 likes Noted, and thank you for writing it out rather than summarising it.
-
Thyroid function tests during substantial weight change Replied, post #20 · Clinical › Bloodwork · 3 Aug 2025 · 2 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
The C-cell question: rodent findings and their human context Replied, post #45 · Compounds › Semaglutide · 31 Jul 2025 · 2 likes Sensible. I would want the same detail before I acted on it either.
-
A field-by-field walk through a certificate of analysis Replied, post #47 · Analytics › COA interpretation · 15 Jul 2025 · 33 likes Reporting rather than recommending, on field-by-field walk through a certificate. What happened is above. Whether it should have is a different question and not one I…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #76 · Compounds › Retatrutide · 8 Jul 2025 · 13 likes Thank you for the correction. I would rather find out here than later.
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #20 · Sourcing › Regulatory · 15 Jun 2025 · 4 likes A label change is a regulatory event with a date and a document. Citing the document is what makes a claim about labelling checkable.
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #28 · Compounds › Semaglutide · 15 Jun 2025 · 1 like Offering a way to settle Semaglutide half-life rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
-
Half-life, steady state, and accumulation worked through Replied, post #103 · Pharmacology › Pharmacokinetics · 12 Jun 2025 · 10 likes One more thing on half-life that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2025 · 29 likes On CagriSema phase 2 paper the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #47 · Evidence › Journal club · 28 May 2025 · 6 likes Right, and stated more narrowly than I would have dared to state it.
-
DXA precision and the least significant change for lean mass — the long version Replied, post #111 · Outcomes › Body composition · 28 May 2025 · 0 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #31 · Meta › Wiki maintenance · 23 May 2025 · 4 likes Building on post #28 rather than restating it. That matches how I use it. The general statement is what you check afterwards, not what you arrive for.
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #42 · Sourcing › Independent verification · 19 May 2025 · 26 likes Post #41 is the version of this I will quote in future. One addition. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #51 · Practice › Reconstitution · 11 May 2025 · 2 likes Post #48 is right about the mechanism and I think understates the practical bit. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
A ten-fold dose error caught before injection Replied, post #27 · Devices › Syringes & needles · 29 Apr 2025 · 1 like Distinguishing three things in the ten-fold dose error caught discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #78 · Wellbeing › Mental health · 22 Apr 2025 · 0 likes Where a member is finding this hard, the useful reply is usually a question rather than an answer, and this subcategory does that well. That holds for the case as…
-
Carryover and the ghost peak from last week's standard Replied, post #39 · Analytics › HPLC & UHPLC · 6 Apr 2025 · 0 likes Worth separating two things that post #37 runs together. A note on how carryover gets discussed rather than on carryover itself: the confident posts get the replies and…
-
Adjudicated events and why the definition matters — the long version Replied, post #70 · Evidence › Trials · 29 Mar 2025 · 9 likes Narrowing post #69, because the general version has more than one answer. An observation about Adjudicated events that I cannot explain and am posting anyway, on the…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 25 Mar 2025 · 0 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #108 · Compounds › Semaglutide · 19 Mar 2025 · 32 likes Post #107 is the version of this I will quote in future. One addition. Published dose-response for semaglutide came up in a thread eighteen months ago and was answered…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #86 · Pharmacology › Receptor biology · 12 Mar 2025 · 1 like Post #82 describes the usual case. This is about the unusual one. GIP receptor biology is genuinely contested. Both agonism and antagonism have been argued to produce…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #23 · Evidence › Journal club · 4 Mar 2025 · 5 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping. If…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #7 · Sourcing › Regulatory · 27 Feb 2025 · 0 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported.
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #42 · Evidence › Journal club · 15 Feb 2025 · 1 like SUSTAIN 6 came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Transit times by route, from a logged dataset — the long version Replied, post #55 · Sourcing › Logistics · 1 Feb 2025 · 18 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. The mechanism is plausible, which…
-
Canadian access and provincial variation Replied, post #26 · Regional › North America · 27 Jan 2025 · 3 likes The most useful contribution is the current published criterion with a link and an access date, rather than an account of what happened to somebody.
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #31 · Practice › Dosing & titration · 26 Jan 2025 · 12 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
When "no data" is the complete and final answer Replied, post #74 · Compounds › Other compounds · 24 Jan 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #19 · Documentation › Doc review · 28 Dec 2024 · 4 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. That is one dataset and I would not…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #68 · Compounds › Semaglutide · 22 Dec 2024 · 1 like Answering the question post #65 raises rather than the one it answers. On Semaglutide half-life: the maintained page in the documentation commons covers the general…
-
Fixed versus detachable needles: the trade-offs Replied, post #63 · Devices › Syringes & needles · 21 Dec 2024 · 0 likes Taking post #62 at face value and following it one step further. Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #15 · Nutrition & Training › Protein & intake · 21 Nov 2024 · 28 likes Practical note on Meeting a protein target: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance…
-
Taste changes and food aversion, reported and discussed Replied, post #43 · Practice › Side effects · 21 Nov 2024 · 17 likes Answering the taste changes and food aversion question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #40 · Sourcing › Independent verification · 21 Nov 2024 · 30 likes Answering the question post #38 raises rather than the one it answers. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #146 · Clinical › Bloodwork · 26 Oct 2024 · 13 likes Where the bring a laboratory reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Food noise reducing and the disorientation that can follow Replied, post #9 · Wellbeing › Mental health · 19 Sep 2024 · 31 likes I read the earlier replies on food noise twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #13 · Practice › Side effects · 10 Sep 2024 · 22 likes Post #9 and I disagree about the size of the effect, not about the direction. The reason nausea timeline keeps being re-asked is that the answer is conditional and…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #7 · Compounds › Secretagogues & GH axis · 27 Aug 2024 · 31 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #25 · Devices › Syringes & needles · 24 Aug 2024 · 7 likes A detachable luer needle plus hub can retain enough volume to matter. Whether it matters to you depends on your dose, and the arithmetic is worth doing once.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #40 · Nutrition & Training › Hydration & electrolytes · 14 Aug 2024 · 2 likes Adding salt to food is the intervention most consistently reported as helping and is also the one least likely to cause harm. It is worth stating the boring hypothesis…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #96 · Compounds › Retatrutide · 22 Jul 2024 · 20 likes Post #95 and I disagree about the size of the effect, not about the direction. One more thing on Retatrutide dose escalation that took me far too long to see: the two…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #62 · Practice › Interactions · 17 Jul 2024 · 16 likes That reframing is the whole thing. The facts I already had.
-
The topic list is dense — is that deliberate? Replied, post #3 · Meta › Site feedback · 8 Jul 2024 · 0 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
-
Cold packs, phase-change material, and what survives ten days Replied, post #81 · Sourcing › Logistics · 7 Jul 2024 · 0 likes Post #77 and I disagree about the size of the effect, not about the direction. On cold packs, I would rather understate and be corrected upward than overstate and be…
-
Assessing a warm arrival: the decision process — one year on Replied, post #45 · Sourcing › Logistics · 30 May 2024 · 19 likes Coming back to post #44, because the follow-up matters more than the original answer. Document outcomes rather than forecasting them. A forecast in this category reads…